Cleveland BioLabs, Inc. and Roswell Park Cancer Institute (RPCI) today announced the publication of studies in Oncotarget describing the preclinical efficacy of Curaxin CBL0137 as a single agent and in combination with the ...
Nov 14, 2014
not rated yet | 0
Indiana University cancer researchers have found that a simple blood test might help diagnose pancreatic cancer, one of the most deadly forms of the disease.
Oct 28, 2014
5 / 5 (1) | 0